Lymphoid Leukemia — Trials

Lymphoid Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

3,262 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 827
Recruiting: 465
Ph III recruiting: 43
Growth YoY: −7.8%
Industry share: 18%
Top sponsor: City of Hope Medical Center
Termination share: 33.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (489)

clinicaltrialsPublishedShowing 1–36 of 36 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03462719	A Study of the Combination of Ibrutinib Plus Venetoclax Versus Chlorambucil Plus Obinutuzumab for the First-line Treatment of Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)(GLOW)	active not recruiting	Phase 3	211	Janssen Research & Development, LLCINDUSTRY	14	Sep 28, 2026	clinicaltrials
NCT06073821	Study of Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Obinutuzumab in Participants With Chronic Lymphocytic Leukemia (CLL)	active not recruiting	Phase 3	652	BeOne Medicines